반응식
[CH:1]1([C:4]2[C:5]([O:13][CH2:14][C:15]([F:18])([F:17])[F:16])=[CH:6][C:7]([C:10]([OH:12])=O)=[N:8][CH:9]=2)[CH2:3][CH2:2]1.[CH:19]1([C:22]([NH2:30])([C:24]2[N:28]=[C:27]([CH3:29])[O:26][N:25]=2)[CH3:23])[CH2:21][CH2:20]1>>[CH:19]1([C:22]([NH:30][C:10]([C:7]2[CH:6]=[C:5]([O:13][CH2:14][C:15]([F:18])([F:17])[F:16])[C:4]([CH:1]3[CH2:2][CH2:3]3)=[CH:9][N:8]=2)=[O:12])([C:24]2[N:28]=[C:27]([CH3:29])[O:26][N:25]=2)[CH3:23])[CH2:21][CH2:20]1참가 물질
3
반응물 2
생성물 1
실험 절차
The title compound was synthesized in analogy to Example 24d, using 5-Cyclopropyl-4-(2,2,2-trifluoro-ethoxy)-pyridine-2-carboxylic acid (Example 48c) and 1-Cyclopropyl-1-(5-methyl-[1,2,4]oxadiazol-3-yl)-ethylamine (CAN 1155536-64-3) as starting materials and isolated (190 mg, 27%) as alight yellow oil; MS (ESI, m/z): 411.0 (M+H+).
후처리
- customisolated (190 mg, 27%) as alight yellow oil
출처 및 근거
- ORD 기록
- ord-d436c413f19f4673825b0cffbc87a67d
- 출처 데이터셋
- uspto-grants-2016_08
- 특허 번호
- US09409866B2
연결된 노트
불러오는 중…